Google
GALDY — GALDERMA GROUP AG (Healthcare >> Drug Manufacturers - Specialty & Generic)
GALDY FAQ
What is GALDY's ROE?
GALDERMA GROUP AG reports a Return on Equity (ROE) of 7.52%.
What is GALDY's dividend yield?
GALDERMA GROUP AG offers a dividend yield of 0.22%.
What is GALDY's Deepscope Quality Score?
Deepscope rates GALDY's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GALDY?
Deepscope's AI Timing Score for GALDY is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GALDY belong to?
GALDERMA GROUP AG is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 40.41
Price
-0.17
(-0.42%)
Day Change
|
|
|---|
GALDY, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 40.41 |
| PBV / Sector |
1.16 / 2.76
GREAT
|
| Earning Per Share | 2.61 |
| PE / Sector |
N/A / 23.64
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
0.62 M
GREAT
|
| Average 1W Daily Value |
0.65 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
52% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:37 |
| Symbol | GALDY |
| Name | GALDERMA GROUP AG |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 1,172.84 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 9,478.92 / 9,835.56 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Zählerweg 10, Zug, Switzerland, 6300
Phone: 41 58 455 85 92
Website: https://www.galderma.com
Employees: 7,676
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
